Showing 49 - 72 of 201 results
Partin Stepping Down as Director
Spotlight on UTUC
Neoadjuvant Chemotherapy and Muscle-Invasive Bladder Cancer
Treatment Goals for NMIBC: What Do Patients Think?
Men and Women Respond Differently to Immune Checkpoint Blockade
New Guidance for Treating Early Testicular Cancer
Ultrasound and Testicular Tumors
“Unclassifiable” Kidney Cancer: New Insights
RCC: Local Recurrence Can Be Cured with Surgery
Urogynecological Surgery Case Study—New Program’s Minimally Invasive Approach
Our Unique Approach to Female Urologic Reconstruction | Dr. Marisa Clifton
JAMA Study: Immunotherapy May Affect Male Fertility
Early-Stage Testicular Cancer: Treating with Surgery Alone?
Newly Discovered Cells Shed Light on Immunotherapy in Kidney Cancer
The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer
Shedding Light on the “Trickle-Down” Effect of Mutated Genes in Kidney Cancer
Our Multidisciplinary Kidney Cancer Group
If Bladder Cancer Responds Well to Chemotherapy, Is It Safe to Skip the Cystectomy?
Can Biomarkers Predict Who Will Benefit from Chemotherapy in Bladder Cancer?
Tackling a Rare, Aggressive Form of Cancer
New Immunotherapy Targets: B Cells
Targeting Hypoxia in Bladder Cancer
Coulter Joins Research Faculty
Kidney Cancer Q&A
Connect with Johns Hopkins Medicine
Join Our Social Media Communities >
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
Powered by BROADCASTMED